Singapore & 6th Annual Showcase in Times of Israel

Singapore a short-cut to China, say visiting officials

Sometimes smaller is better – and Israeli companies can find a foothold in China’s biggest markets via one of Asia’s smallest countries, says Singaporean business executives

By David Shamah, The Times of Israel

panel1

Panel discussion, “Singapore: The Asia-Pacific Gateway,” at the 6th Annual Trendlines Company Showcase, featuring panelists (l to r): CEO, PrimePartners Corporate Finance, Gerald Ong, Singaporean businessman Mati Nursalla, Moderator Manor Zemer, Senior VP, Singapore Exchange Nasser Ismail, and Drew and Napier Deputy Managing Director Boon Ann Sin. Photo: The Trendlines Group

For many Israeli start-ups, getting a piece of the Chinese market is a much sought-after dream. But, asks Nasser Ismail of the Singapore Stock Exchange, why stop at China? “If you go to China, then China is where you will do business, and that’s fine. But Singapore helps you get not only to China, but to many other countries in Asia. China’s fine, but there are lots more opportunities in the rest of Asia too.”

Ismail, along with other top Singaporean investors and business officials, were in Israel to attend the annual company showcase of the Trendlines Group, which runs incubators for early-stage Israeli start-ups in the medical device and agriculture technology sectors. Displaying their wares before an audience of some 500 investors from Israel and around the world were Trendlines portfolio companies such as EdenShield, which is developing pesticides based on herbs and other natural ingredients, MiRobot, which is developing automated milking systems for farms, Steak TzarTzar, which is developing a grasshopper-based meat substitute, and others.

But Singapore was much on the minds of the Trendlines folks – not least because the company, which guides start-ups towards exits, had an exit itself last November, when it went public on the the Catalist of the Singapore Exchange Securities Trading Limited (SGX-ST). According to the company, it received “strong interest from investors,” raising $25 million in its initial public offering, “and indications of interests from investors significantly exceeded the number of shares offered.”

Read the full article on The Times of Israel.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize
Contrast